Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
The Covid-19 vaccine will be given to 100 healthcare providers across 166 sites in Tamil Nadu, as part of the nationwide vaccine rollout to be launched by Prime Minister Narendra Modi on Saturday, said Dr Vinay Kumar, Joint Director, Directorate of Public Health Care and Preventive Medicine, Chennai.
Tamil Nadu is fully equipped for the vaccine rollout and has made all arrangements and facilities like the cold chains that involved transportation and storage of the vaccines at 2-8 degree Celsius. Healthcare providers at various levels have been trained on the vaccination, he said, while speaking at a Media Sensitisation Workshop on Covid-19 vaccine organised by the Press Information Bureau (PIB).
Across India, over 4.8 lakh healthcare providers, including doctors, have registered through the Co-WIN software to be vaccinated, he said in a release from PIB. The Government is taking steps to create awareness and allay fear and hesitancy among the people. Ten eminent persons will get vaccinated on Saturday after the Prime Minister launches the vaccination drive. The list of the personalities, however, is yet to be finalised, he added.
The choice of vaccine (Covishield and Covaxin) is purely voluntary. It is important that the recipient is given the same vaccine during the second dose after 28 days, he added.
When asked if media personnel will be included in the category of frontliners, Kumar said the State officials have already written to the Centre in this regard and are awaiting a reply. To another query on when the registration for public will open on the Co-WIN platform, he answered that there is already a provision for self-registration, which can be used after the instruction given by the Government, following the rollout for frontline workers and other prioritised groups.
Melvin George, Co-Investigator in Covaxin trials at SRM Hospital and Associate Professor, Department of Clinical Pharmacology, SRM Medical College Hospital, Kattankulathur, said that early clinical trials showed the vaccine to have immunogenicity as high as 88 per cent, which was very promising.
The cost-effectiveness of Covaxin and Covishield along with storage requirements make it a more compelling option for the Indian population. On claims of mutation of virus, he said that viruses usually take more time for multiple mutations to make the vaccine ineffective. The fear of the vaccine not being ineffective due to these minor mutations could be laid aside for the time being at least, he said.
Regarding possible side effects, George said that there could be minor fever, tiredness or nausea for one or two days.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
Here is a checklist that equips you to discern the market nuances
Sensex, Nifty 50 have witnessed sharp decline
The fund has consistently outperformed S&P BSE 100 TRI over one, three and five years
Returns are superior to immediate annuity plans, but SCSS can secure better rates for new investors sooner if ...
With the public looking beyond mainstream media for reports from the ground, independent digital platforms are ...
While Supreme Court has cleared the way for women seeking longer tenures and senior roles in the Indian Army, ...
Mughal Gardens in the Capital open to visitors — albeit with Covid-19 protocol — for the annual Udyanotsav
Salty, buttery, cheese coated or with maple syrup and bacon — popcorn is lending its adaptable self to gourmet ...
Its name is the starting point of a brand’s journey and can make a big difference in the success sweepstakes
Sober spirits are the in thing
A peek into where ad spends went last year and where they are headed tomorrow
Can Swiggy Instamart disrupt the ecommerce groceries space, currently ruled by the Amazons and Big Baskets? ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor